Skip to main content
Christopher Martin, MD, Internal Medicine, New York, NY

ChristopherMartinMDCAQSM

Internal Medicine New York, NY

Sports Medicine (Non-Surgical)

Physician - Sports Medicine

Dr. Martin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Martin's full profile

Already have an account?

Education & Training

  • Ross University School of Medicine
    Ross University School of MedicineClass of 2015

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2021 - 2024
  • LA State Medical License
    LA State Medical License 2019 - 2021
  • NJ State Medical License
    NJ State Medical License 2016 - 2020
  • American Board of Emergency Medicine Sports Medicine
  • American Board of Internal Medicine Internal Medicine

Press Mentions

  • ADC Therapeutics to Participate in Cowen 41st Annual Health Care Conference
    ADC Therapeutics to Participate in Cowen 41st Annual Health Care ConferenceFebruary 25th, 2021
  • ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and Other ADCs for Hematologic and Solid Tumor Indications in Greater China and Singapore
    ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and Other ADCs for Hematologic and Solid Tumor Indications in Greater China and SingaporeDecember 14th, 2020
  • ADC Therapeutics Announces FDA Accepts Biologics License Application and Grants Priority Review for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
    ADC Therapeutics Announces FDA Accepts Biologics License Application and Grants Priority Review for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell LymphomaNovember 20th, 2020
  • Join now to see all